Bradford Barton serves as Executive at Alliqua BioMedical, Inc., where they oversee executive responsibilities. Since joining the company, Bradford Barton has executed 10 insider transactions totaling $60.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 21, 2017 involved selling 67,536 shares valued at $28.4K.
Bradford Barton currently holds 558,822 shares of Alliqua BioMedical, Inc. (ALQA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bradford Barton has been a net buyer of ALQA stock. They have purchased $60.6K and sold $0 worth of shares.
Bradford Barton's most recent insider trade was on Sep 21, 2017, when they sold 67,536 shares at $0.42 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 23, 2017 | ALQA | $0 | Award | 205,715 | $N/A | Discretionary |
| Apr 3, 2017 | ALQA | $30.0K | Purchase | 75,000 | $0.40 | Discretionary |
| May 11, 2016 | ALQA | $0 | Award | 100,000 | $N/A | Discretionary |
| Feb 9, 2016 | ALQA | $0 | Award | 24,658 | $N/A | Discretionary |
| Nov 6, 2015 | ALQA | $14.8K | Purchase | 5,000 | $2.97 | Discretionary |
| Jun 8, 2015 | ALQA | $15.8K | Purchase | 3,000 | $5.25 | Discretionary |
| Mar 6, 2015 | ALQA | $11.8K | Payment | 2,225 | $5.29 | Discretionary |
| Feb 6, 2015 | ALQA | $0 | Award | 100,000 | $N/A | Discretionary |